Published in Medical Patent Week, March 20th, 2005
The patent, entitled "Pharmaceutical compositions for buccal delivery of pain-relief medications," relates to a narcotic analgesic formulation delivered into the human body by way of the buccal mucosa in the mouth.
The formulations covered by the patent are applications of the company's proprietary RapidMist drug-delivery technology and, according to the company, are designed to deliver pain-relief medications such as morphine and fentanyl in a safe, simple, fast, effective and convenient alternative to injections and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2005-03-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.